Testing effectiveness (Phase 2)Looking for participantsNCT06812039
What this trial is testing
HAIC Combined with Donafenib and Sintilimab As Perioperative Treatment for Resectable Hepatocellular Carcinoma Patients At High Risk of Recurrence
Who this might be right for
Hepato Cellular Carcinoma (HCC)
Fudan University 165